MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

NCT00605878 ·Status: RECRUITING

Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis

NCT04761978 ·Status: WITHDRAWN

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

NCT00310492 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

NCT01756898 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

NCT03158012 ·Status: COMPLETED ·Phase: PHASE1

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

NCT06837454 ·Status: RECRUITING

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359 ·Status: ACTIVE_NOT_RECRUITING

A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

NCT06169527 ·Status: ACTIVE_NOT_RECRUITING

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

NCT05935085 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT03533751 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

NCT05916365 ·Status: COMPLETED ·Phase: PHASE3

Targeting Staphylococci in Atopic Dermatitis

NCT05502185 ·Status: UNKNOWN

Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis

NCT06039241 ·Status: RECRUITING

Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.

NCT05575882 ·Status: RECRUITING ·Phase: NA

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

NCT05639738 ·Status: TERMINATED ·Phase: NA

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

NCT05098821 ·Status: RECRUITING

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT06899204 ·Status: RECRUITING

Frequency of Palpebral Involvement in Adult With Atopic Dermatitis

NCT04826744 ·Status: RECRUITING

Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients

NCT06983561 ·Status: COMPLETED

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

NCT03989206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT05250115 ·Status: TERMINATED

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

NCT05669794 ·Status: ACTIVE_NOT_RECRUITING

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

NCT04836858 ·Status: COMPLETED ·Phase: PHASE2

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

NCT05602207 ·Status: COMPLETED ·Phase: PHASE4